ArticleFrontiers in oncology2026
Fibrin-associated large B-cell lymphoma arising within a hepatic cystic lesion: a case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibrin-associated large B-cell lymphoma (FA-LBCL) is a rare Epstein-Barr virus (EBV)-associated B-cell neoplasm typically arises within chronic fibrin deposits in confined anatomical spaces, whether natural or acquired. It is most commonly reported in association with cardiac myxomas, vascular prostheses and organizing hematomas. Here, we describe the first documented case of FA-LBCL arising within a hepatic cystic lesion. A 69-year-old immunocompetent man was found incidentally to have a large cystic mass in the right hepatic lobe without contrast enhancement on imaging. The lesion was surgically resected. Histologic examination revealed scattered aggregates of large atypical B lymphocytes embedded in abundant fibrin and necrotic material without invasive growth. Tumour cells were positive for pan-B cell markers CD20 and CD79α, exhibited a MUM1 index of approximately 50%, demonstrated a high proliferative index, and tested positive for Epstein-Barr virus-encoded RNA (EBER) by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.